Glucagon-like peptide-1 receptor agonist – Biasly

Glucagon-like peptide-1 receptor agonist Follow

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, Altimmune, and UnitedHealth and Encourages Investors to Contact the Firm By Investing.com

Nasdaq

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Equinix, Harbor Diversified, Altimmune, and Un...

Investing
May 26, 2024

Center

Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk's Ozempic

obesity

Roche strikes $3.1 billion deal to buy obesity-drug maker Carmot Therapeutics billion in race to rival Novo Nordisk's Ozempic

MarketWatch
Dec 04, 2023

Center